A formulation for a stabilized capsule for oral administration of a hydrophobic pharmaceutically active agent; comprising a non-aqueous solubilizer selected from 2-pyrrolidone, N-alkylpyrrolidones and combinations thereof; and a capsule stabilizing agent selected from mono-, di- and triglycerides, mono- and di-fatty esters of polyethylene glycol, fatty acids and combinations thereof wherein capsule integrity is maintained for at least 24 hours is disclosed.

 
Web www.patentalert.com

< PRO697 polypeptides

< Peptides as NS3-serine protease inhibitors of hepatitis C virus

> Anti-PRO788 antibodies

> Methods of preparing and using a viral vector library

~ 00245